KCG
CRL icon

Knight Capital Group’s Charles River Laboratories CRL Stock Holding History

Knight Capital Group’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q2 		$315K Buy
+7,683
New +$329K 0.01% 2181

Other funds holding CRL

PIM
Perkins Investment Management Chicago, Illinois $8.09B AUM 25.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
FC
Fairpointe Capital Chicago, Illinois $66.3M AUM 101.32% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Knight Capital Group's CRL Position: Q2 2013 in Review

Knight Capital Group opened a new position in Charles River Laboratories (CRL) in Q2 2013: 7,683 shares worth $315K. The stake represents 0.01% of the portfolio and ranks #2181 among its holdings.

225 funds tracked by Wall St. Rank hold CRL as of Q2 2013.

  • Knight Capital Group held 7,683 shares of Charles River Laboratories worth $315K as of Q2 2013.
  • Charles River Laboratories was a new Knight Capital Group position in Q2 2013.
  • Charles River Laboratories made up 0.01% of Knight Capital Group's portfolio in Q2 2013, its #2181 holding.
  • 225 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2013.

Based on Knight Capital Group's 13F filing for Q2 2013, filed 8 Aug 2013.